Vaccine based on several COVID strains may be developed in Russia

Scientists of the Russian Gamaleya National Centre of Epidemiology and Microbiology consider the possibility to develop polyvalent vaccines against COVID-19 on the basis of various strains such as Delta and Omicron – as reported by TASS

“[The possibility] is being considered and discussed to develop such a polyvalent Sputnik [vaccine] which includes Delta, Omicron and Wuhan variants [Wuhan strain, the original strain of coronavirus] <...> It is possible to develop such a more complex vaccine,” said Denis Logunov, Centre’s Deputy Director.